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INTRODUCTION
In parotid acinar cells, stimulation of β -adrenergic
receptors provokes amylase release (1). The amy-
lase release is depended on the increase in intracel-
lular cAMP levels stimulated with β -adrenergic re-
ceptors but occurs independent of elevation of in-
tracellular calcium ion (Ca2+) levels. Activation of
cAMP-dependent protein kinase (PKA) followed by
the increase in intracellular cAMP levels is thought
to be an essential step in this process (1). On the
other hand, it has also been thought that protein
kinase C (PKC) activation is involved in amylase
release in parotid acinar cells (2-4). We here investi-
gated the role of PKC on amylase release induced
by the β -adrenergic agonist isoproterenol (IPR) in
rat parotid acinar cells.
INVOLVEMENT OF PKC IN IPR-INDUCED
AMYLASE RELEASE
The PKC family consists of at least 10 members,
which are classified into three subgroups based on
their structural characteristics and cofactor require-
ment. They include the conventional cPKC (α, βI,
βII and γ), stimulated by Ca2+ and diacylglycerol
(DAG) or phorbol esters ; the novel nPKC (δ, ε, η
and θ), activated by DAG and phorbol esters but Ca2+
independent ; and the atypical aPKC (ζ and ι/λ),
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unresponsive to Ca2+, DAG and phorbol esters (5,
6). Of those, the expression of PKCα, δ, ε and ζ
has been reported in rat parotid acinar cells (7, 8).
In the presence of calphostin C, an inhibitor of DAG-
sensitive PKC, IPR-induced amylase release was re-
duced. Since β -adrenergic receptor activation does
not elicit Ca2+ mobilization, this observation suggests
that a Ca2+-independent and DAG-sensitive PKC,
i.e. a novel PKC such as PKCδ, is involved in IPR-
induced amylase release. Then, the effect of the
PKCδ inhibitor rottlerin was examined. The inhibi-
tor mimicked the effect of calphostin C. Although
rottlerin has been used widely as a PKC-δ inhibitor,
this polyphenolic compound has also been reported
to cause a general inhibition of the mitochondrial
metabolism which correlated with a depletion of the
cellular ATP concentration (9, 10). Then we exam-
ined the effect of rottlerin on cellular ATP level in
rat parotid acinar cells. However, the cellular ATP
level was scarecely reduced by rottlerin. Therefore,
it is unlikely that the inhibition of IRP-induced amy-
lase release by rottlerin is caused by a toxic effect.
ACTIVATION OF PKC BY IPR
It is known that activated isoforms of PKC, includ-
ing PKCδ, are phosphorylated and translocated from
the cytosol to the cell membrane (11). When parotid
acinar cells were stimulated with IPR, the increase
in the amount of phosphorylated-PKCδ in the mem-
brane fraction was observed by Western blotting
using anti-phosphorylated-PKCδ antibody. This ob-
servation suggests that stimulation of β -adrenergic
receptor induces PKCδ activation in parotid acinar
cells. Further, we directly examined kinase activity
of PKCδ using PKCδ -specific immunoprecipitates.
When the kinase activity was measured with PKCδ
purified from cell lysate by immunoprecipitation,
the activity was shown to be increased in the aci-
nar cells by treatment with IPR. Next we exam-
ined the effect of the PKA inhibitor H89 on IPR-
induced PKCδ activation by detection of phospho-
rylated-PKCδ in the membrane fraction. In the pres-
ence of H89, IPR failed to increase the amount of
phosphorylated-PKCδ in the membrane fraction, in-
dicating that this PKA inhibitor inhibits IPR-induced
PKCδ activation. These results suggest that PKCδ
is activated via PKA activation in the IPR-stimulated
rat parotid acinar cells.
MARCKS PHOSPHORYLATION INDUCED
BY IPR
Myristoylated alanine-rich C kinase substrate
(MARCKS) is a major cellular substrate for PKC
(12). The involvement of MARCKS in the IPR-in-
duced amylase release was examined in parotid
acinar cells. The N-terminal sequence peptide of
MARCKS (MANS) has been shown to be a useful
inhibitor of MARCKS function because this peptide
suppresses the secretory function in vivo (13, 14)
and in cultured cells (15). In parotid acinar cells pre-
treated with the MANS peptide, IPR-induced amy-
lase release was reduced, suggesting the involve-
ment of MARCKS in IPR-induced amylase release.
Involvement of phosphorylation of MARCKS by
PKC in secretory function has been demonstrated
in chromaffin cells (16, 17), insulin-producing INS-1
cells (18), bovine luteal cells (19), and SH-SY5Y hu-
man neuroblastoma cells (20). When we exam-
ined the effect of IPR on MARCKS phosphoryla-
tion by Western blotting using anti-phosphorylated
MARCKS antibody, this β-agonist induced MARCKS
phosphorylation in parotid acinar cells. The IPR-
induced MARCKS phosphorylation was inhibited
in the presence of a PKA inhibitor, H89, implying
that MARCKS phosphorylation stimulated by IPR
is evoked via PKA activation in parotid acinar cells.
In the presence of the PKCδ -specific inhibitor, rot-
tlerin, the MARCKS phosphorylation was also in-
hibited. These results suggest that PKCδ activated
by IPR stimulation via PKA activation provokes
MARCKS phosphorylation.
Taken together, it is most likely that PKA-PKCδ -
MARCKS pathway is involved in IPR-induced amy-
lase release in rat parotid acinar cells.
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